CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +300,000 | $16.00 | $4.8M | 4,603,418 |
| 2024-09-17 | Flynn James E 10% owner | Purchase | +35,000 | $18.00 | $630K | 897,587 |
| 2024-09-17 | Flynn James E 10% owner | Purchase | +35,000 | $18.00 | $630K | 897,587 |
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,680,520 | $18.00 | $30.2M | 4,303,418 |
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +152,480 | $18.00 | $2.7M | 2,652,575 |
Page 1 of 1 · 5 trades